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ABSTRACT
Madelung disease or multiple symmetric lipomatosis (MSL) is a rare entity among the overgrowth syndromes. It is 
characterized by painless non-encapsulated and symmetric fatty deposits in the neck, torso, mammary, and abdominal 
areas, and in the upper and lower limbs. The etiology of the disease is still unknown. Chronic alcohol consumption may 
play a role in adipocyte hyperplasia in genetically susceptible individuals. Besides the overgrowth of adipose tissue, patients 
with MSL present features of metabolic syndrome. Patients seek medical attention usually for esthetic reasons. We present 
the case of a middle-aged man who sought the outpatient clinic complaining of bulging masses in the posterior upper 
part of the thorax, the occipital area, and the neck. The masses grew over a period of 2 years. The physical examination 
and imaging study revealed the presence of symmetric lipomatosis. A two-step surgical treatment was undertaken for 
the excision of the lipomatous tissue. The postoperative outcome was uneventful with satisfactory esthetic results.  
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CASE REPORT
A 45-year-old male patient sought medical 
attention because of a growing mass. The lesion 
was in the anterior cervical region initially, but over 
the last 2 years it also appeared in the occipital and 
dorsal regions. At the time of medical evaluation, the 
lesions caused him esthetic embarrassment. He also 
had type 2 diabetes mellitus and asymptomatic 
chronic pancreatitis. He had a history of alcoholic 
abuse of 1 liter/day for 10 years. He denied other 
comorbidities. He had worked as a bricklayer; however, 
due to the deformation caused by the masses, he was 
unemployed.
The physical evaluation revealed bulging masses 
of soft consistency in the anterior cervical region, in the 
pre- and post-auricular regions bilaterally, and on the 
back (Figure 1). The computed tomography imaging 
study showed a prominent unencapsulated excess of 
cervical adipose tissue (Figure 2A-C). There was no 
sign of airway obstruction, hoarseness, cervical, or 
cervical venous engorgement. The mediastinum was 
not involved with the lipomatosis (Figure 3D).
A two-step surgical treatment was scheduled. 
In the first procedure, the anterior cervical mass was 
resected followed by closed vacuum system drainage. 
The occipital mass was resected with similar drainage 
after 1 month in a second surgery. In both surgeries, 
no dissection plan was identified between the adipose 
mass and the surrounding structures.
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The anatomopathological study of the masses 
showed a mature adipocyte proliferation, which was 
compatible with lipomatosis.
Both procedures had a favorable outcome 
(Figure 3) and after 1 year of follow-up the final 
esthetic result was satisfactory. After 1 year, the patient 
was able to look for employment.
DISCUSSION
MSL—which is  cal led Madelung disease, 
Launois–Bensaude disease, or benign symmetrical 
lipomatosis—was first described by Benjamin Brodie 
in 1846, followed by reports by Madelung, and 
Launois and Bensaude, in 1898. MSL is a rare disease 
of fat metabolism. The subcutaneous unencapsulated 
fatty tissue overgrowth is painless and symmetrically 
involves mainly the head, neck, and upper torso, 
and eventually the upper extremities.1 MSL typically 
presents between the third and the fifth decade of 
life and is more prevalent in males,1,2 with the male to 
Figure 1. Pre-operative examination. Note the tumors in 
A and B – the anterior cervical submandibular regions, 
and pre- and post-auricular regions; and C – in the back.
Figure 2. Pre-operative cervical computed tomography 
(A, B, and C) showing the bilateral and symmetric 
increase of the adipose tissue of the submandibular 
(A and C) and posterior cervical (B) regions, which is 
consistent with the diagnosis of lipomatosis. Note the 
lack of lipomatosis in the mediastinum (D).
Figure 3. Early post-operative examination showing 
a favorable esthetic result in both the cervical region 
(A and B) and the back (C).
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female ratio ranging from 15:1 to 30:1. The disease is 
more common in the Mediterranean or in people with 
this ancestry than in the general population, and shows 
an incidence of 1:25,000 in the Italian population.2
MSL does not have a completely defined 
pathophysiology. The adipogenesis is not a result of 
energy excess, but is an active proliferation of the 
adipose tissue. The suggested mechanisms comprise 
a defect of the respiratory chain, and deletions, and 
mutations of mitochondrial DNA.3,4 Lipomatous fat 
deposits may originate from functionally defective 
brown adipose tissue.2 The tumor fatty cells have an 
anomalous metabolic behavior, which is characterized 
by a defect of the catecholamine’s acute lipolytic action, 
and by the long-acting physiological mechanisms 
regulating lipid mobilization in adipose tissue.5-8 
Alcoholic abuse is present in more than 90% of the 
cases.9 A decrease in the beta-adrenergic receptors 
and disturbance in the mitochondrial DNA may be an 
explication of the pathogenic alcohol mechanism.10
The history, epidemiology, and clinical features are 
the basis of MSL diagnosis.10 However, the diagnosis, 
in some cases, may be challenging and frequently 
dismissed due to the high frequency of obesity.1,4 
Patients with MSL often present concomitantly 
metabolic syndrome features as type 2 diabetes mellitus 
or glucose intolerance, hypertension, hyperlipidemia, 
and hyperuricemia. Diseases related to alcohol 
abuse, such as hepatopathy, macrocytic anemia, 
and peripheral neuropathy, are also common in MSL 
patients.11
In 1984, Enzi12 classified MSL into two types 
according to the site of the fat overgrowth. MSL 
type I is characterized by symmetric, circumscribed, 
protruding fat masses. The lesions can be predominantly 
distributed in the parotid glands (hamster cheeks), 
cervical region (horse collar), posterior neck (buffalo 
hump), submental region (Madelung collar), shoulders, 
supraclavicular triangle, and proximal upper limbs. 
In MSL type II, the lipomatous tissue is diffusely 
deposited in the subcutaneous tissue of the abdomen 
and thighs. The appearance resembles an obesity type 
of fat distribution.10,13 A congenital form, in which 
the lipomatosis deposition occurs around the trunk, 
was suggested by Carlsen and Thomsen14 as type III. 
In 1991, Donhauser et al.15 added the type III or 
gynecoid type to Enzi’s classification, which became 
defined as relating to fat deposits mainly located in 
the pelvic region.10,16 Our patient was a middle-aged 
man—a heavy drinker—with lipomatosis restricted to 
the anterior and posterior neck, the parotid region, 
and the upper back torso; therefore, he represented 
MSL type I.
The malignant transformation of MSL is rare.17-19 
Complications are also rare and result from compression 
of the cervical structures by the fatty deposits 
causing dysphagia,20 odynophagia, and hoarseness. 
Mediastinal and retroperitoneal lipomatosis can 
progress causing venous compression.1,21,22 Imaging 
exams, such as computed tomography and magnetic 
resonance imaging, are useful for the evaluation of 
(i) the extension of the adipose tissue deposition; 
(ii) the tracheal compression; (iii) the presence of 
blood vessels within the adipose mass; and (iv) the 
malignant transformation.1 The natural history of the 
disease shows progressive growth of the fat masses, 
with periods of rapid evolution (generally in the early 
stages of the disease), and periods of slow progression 
or a steady phase for a long period; however, no 
spontaneous regression occurs.10
The differential diagnoses of MSL include obesity, 
Cushing syndrome, angiolipomatosis, encapsulated 
fibromas, neurofibromatosis, myxoid liposarcoma, 
lymphoma, salivary gland disease, Frölich syndrome, 
and lipomatosis in patients with HIV.10,23,24
Although alcohol withdrawal and weight loss 
are recommended, these measures are not effective 
to reverse or to stop the progression of the disease. 
Currently, surgery is the only treatment available, so 
the removal of the fat masses remains the only therapy 
of choice. However, the overall recurrence rate is up 
to 63%.10,21
CONCLUSION
Despite the high recurrence rate, the surgical 
approach still needs to be considered. MSL causes 
not only biological disturbances, but also social loss 
(e.g. difficulty maintaining or acquiring a job)—the 
latter of which can be so deleterious that surgery is 
practically imperative.
The patient signed the informed consent 
declaration to permit the publication of this case 
report.
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